loratadine and methyl salicylate

loratadine has been researched along with methyl salicylate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, M; Greiff, L; Persson, CG	1
Głodzinska-Wyszogrodzka, E; Jahnz-Rózyk, K; Płusa, T; Targowski, T	1

Trials

1 trial(s) available for loratadine and methyl salicylate

Article	Year
Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2002, Volume: 89, Issue:4 Topics: Adolescent; Adult; Allergens; alpha-Macroglobulins; Betula; Cross-Over Studies; Double-Blind Method; Female; Fucose; Histamine H1 Antagonists; Humans; Loratadine; Male; Nasal Lavage Fluid; Nasal Mucosa; Plasma; Poaceae; Pollen; Rhinitis, Allergic, Seasonal	2002

Article

Year

Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2002, Volume: 89, Issue:4

Topics: Adolescent; Adult; Allergens; alpha-Macroglobulins; Betula; Cross-Over Studies; Double-Blind Method; Female; Fucose; Histamine H1 Antagonists; Humans; Loratadine; Male; Nasal Lavage Fluid; Nasal Mucosa; Plasma; Poaceae; Pollen; Rhinitis, Allergic, Seasonal

2002

Other Studies

1 other study(ies) available for loratadine and methyl salicylate

Article	Year
Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis. Allergy, 2003, Volume: 58, Issue:7 Topics: Administration, Inhalation; Adult; Allergens; Anti-Allergic Agents; Betula; Biomarkers; Chemokines, CC; Conjunctivitis, Allergic; Desensitization, Immunologic; Drug Therapy, Combination; Edible Grain; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Loratadine; Male; Poaceae; Poland; Pollen; Rhinitis, Allergic, Seasonal; Statistics as Topic; Treatment Outcome	2003

Article

Year

Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.

Allergy, 2003, Volume: 58, Issue:7

Topics: Administration, Inhalation; Adult; Allergens; Anti-Allergic Agents; Betula; Biomarkers; Chemokines, CC; Conjunctivitis, Allergic; Desensitization, Immunologic; Drug Therapy, Combination; Edible Grain; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Loratadine; Male; Poaceae; Poland; Pollen; Rhinitis, Allergic, Seasonal; Statistics as Topic; Treatment Outcome

2003